As mentioned, Palantir has declined 32% from its record high in the last seven trading days, but the statistics suggest the ...

Equities researchers at Wedbush boosted their Q4 2024 earnings per share estimates for Playtika in a research report issued on Wednesday, February 26th. Wedbush analyst M. Pachter now forecasts that ...

Research analysts at Wedbush lowered their Q1 2025 EPS estimates for Travere Therapeutics in a report released on Monday, February 24th. Wedbush analyst L. Chico now expects that the company will post ...

Nvidia's post-earnings plunge pulled the stock back near January’s lows. Analysts have remained bullish, and said they expect Nvidia to be a DeepSeek beneficiary.

Super Micro stock plunged 26% this week, extending the stock’s long streak of volatility as investors weigh the company’s AI-fueled growth against questionable accounting practices, growing ...

Wedbush analyst Nick Setyan downgraded the shares of Dine Brands Global Inc (NYSE:DIN) from Outperform to Neutral and lowered ...

Praxis Precision Medicines (NASDAQ:PRAX) announced Friday that the company will advance its Essential3 program for its lead asset ulixacaltamide against the neurological disorder essential tremor, ...

Williams-Sonoma (WSM) is expected to issue a cautious 2025 outlook when it reports fourth-quarter results next month amid softening demand trends for home furnishings goods, Wedbush Securities said in ...

Wedbush analyst Daniel Ives maintained a Buy rating on Elastic (ESTC – Research Report) today and set a price target of $135.00. The company’s ...

Analyst cuts Dine Brands to neutral after the “Really Big Meal Deal” offers value but doesn’t improve same-store sales at ...

The electric vehicle giant’s stock hit a fresh 2025 low on Thursday, now down 25% year to date. Tesla shareholders haven’t ...

Palantir stock has been losing following news of DoD budget cuts. Four US politicians have loaded up on PLTR shares this year ...